Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
E. Landeloos, J. Pozniak, N. Roda…·J.-C. Marine
The paper identifies NK cells as contributors to resistance to anti-PD1 therapy in immune-excluded melanomas using single-cell RNA sequencing and spatial proteomics.
J. Pozniak, D. Pedri, E. Landeloos…·J.-C. Marine
This study identifies a TCF4/BRD4-dependent regulatory network that drives cross-resistance to ICB and targeted therapy in melanoma by analyzing scRNA-seq data from a longitudinal cohort.
S. Naulaerts, D. M. Borras, A. A. Martinez…·A. D. Garg
This study identifies distinct CD8+T cell states in cancer patients using multi-omics data, showing that dysfunctional states resist immunotherapy while exhausted states can be targeted with specific treatments.
J. Qian, S. Olbrecht, B. Boeckx…·D. Lambrechts
This study profiles single cells from multiple cancer types to create a pan-cancer blueprint of stromal cell heterogeneity, identifying shared and unique cell populations and their characteristics.
F. M. Bosisio, A. Antoranz, M. M. Bolognesi…·V. Boecxstaens
The paper characterizes immune heterogeneity in primary melanoma using single-cell multiplex analysis, revealing functional subcategories of lymphocytic patterns and their prognostic significance.